A look at the factors driving growth and future potential in Latin America’s largest market

In recent years, the pharmaceutical sector in Latin America has experienced significant growth. This has been driven by 1) an increase in average life expectancy resulting in an expanding elderly cohort, which has additional healthcare needs, 2) an increase in disposable income, and 3) local companies’ investments in R&D. Backed by a variety of investments and the growing need for pharmaceutical innovation, Brazil has emerged as a prominent contributor to the development of specialty medications.

To learn more and read the article, please click here.

About the author.


20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.

No Comments. Leave a comment  

Leave a Reply

Your email address will not be published. Required fields are marked *